Literature DB >> 21811789

Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.

Ewa Soltysinska1, Stefanie Thiele, Søren Peter Olesen, Oleg E Osadchii.   

Abstract

It is uncertain if downregulation of β-adrenoceptor signaling pathway is promoted by an enhanced adrenergic tone at an early stage of cardiac disease, or it develops secondary to detrimental local myocardial changes in advanced heart failure. We examined the integrity of β-adrenoceptor signaling pathway upon chronic infusion of isoproterenol, a β-adrenoceptor agonist, at a dose producing no structural left ventricular (LV) remodeling and systolic dysfunction. Subcutaneous isoproterenol infusion (400 μg kg(-1) h(-1) over 16 days) to guinea pigs using osmotic minipumps produced no change in cardiac weights, LV internal dimensions, myocyte cross-sectional area, extent of interstitial fibrosis, and basal contractile function. Isolated, perfused heart preparations from isoproterenol-treated guinea pigs exhibited attenuated responsiveness to acute β-adrenoceptor stimulation, as evidenced by reduced LV developed pressure increase, less shortening of LV epicardial monophasic action potential and effective refractory period, and less myocardial cyclic adenosine monophosphate elevation, in response to isoproterenol exposure, when compared to saline-treated controls. Pharmacological responses to forskolin, an activator of the adenylate cyclase catalytic subunit, were well preserved in isoproterenol-treated hearts. Downregulation of β-adrenoceptor-mediated effects upon chronic isoproterenol infusion was associated with markedly reduced stimulatory G-protein α-subunit (G(sα)) myocardial expression levels. No change in expression levels of β-adrenoceptors, G-protein-coupled receptor kinase 2, inhibitory G-protein α-subunit (G(iα2)), and Ca(v)1.2 and K(v)7.1 ion channels was determined in isoproterenol-treated hearts. We therefore conclude that sustained adrenergic overstimulation may promote downregulation of myocardial β-adrenoceptor-mediated effects independently of structural LV remodeling and systolic failure, an effect attributed to β-adrenoceptor uncoupling from adenylate cyclase due to reduced G(sα)-protein expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21811789     DOI: 10.1007/s00424-011-1005-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  68 in total

1.  Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.

Authors:  T H Fan; C S Liang; S Kawashima; S P Banerjee
Journal:  Eur J Pharmacol       Date:  1987-08-11       Impact factor: 4.432

2.  Ventricular beta-adrenoceptors in adriamycin-induced cardiomyopathy in the rabbit.

Authors:  E A Woodcock; L Arnolda; B P McGrath
Journal:  J Mol Cell Cardiol       Date:  1988-09       Impact factor: 5.000

3.  Ontogeny of G-protein expression: control by beta-adrenoceptors.

Authors:  J L Zeiders; F J Seidler; T A Slotkin
Journal:  Brain Res Dev Brain Res       Date:  2000-04-14

4.  Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.

Authors:  M Böhm; D Beuckelmann; L Brown; G Feiler; B Lorenz; M Näbauer; B Kemkes; E Erdmann
Journal:  Eur Heart J       Date:  1988-08       Impact factor: 29.983

5.  G(i)-dependent suppression of beta(1)-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs.

Authors:  H K Ranu; J C Mak; P J Barnes; S E Harding
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

6.  Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle.

Authors:  S E Harding; S M Jones; G Vescovo; F Del Monte; P A Poole-Wilson
Journal:  Eur J Pharmacol       Date:  1992-11-13       Impact factor: 4.432

7.  Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion.

Authors:  H K Hammond; D A Roth; P A Insel; C E Ford; F C White; A S Maisel; M G Ziegler; C M Bloor
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

8.  Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.

Authors:  Nazha Hamdani; Walter J Paulus; Loek van Heerebeek; Attila Borbély; Nicky M Boontje; Marian J Zuidwijk; Jean G F Bronzwaer; Warner S Simonides; Hans W M Niessen; Ger J M Stienen; Jolanda van der Velden
Journal:  Eur Heart J       Date:  2009-05-31       Impact factor: 29.983

9.  Dissociation between regional dysfunction and beta-adrenergic receptor signaling in heart failure.

Authors:  T Anzai; N C Lai; M Gao; H K Hammond
Journal:  Am J Physiol       Date:  1998-10

10.  Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia.

Authors:  F G Spinale; G E Tempel; R Mukherjee; D M Eble; R Brown; C A Vacchiano; M R Zile
Journal:  Cardiovasc Res       Date:  1994-08       Impact factor: 10.787

View more
  11 in total

Review 1.  Molecular Mechanisms of Sympathetic Remodeling and Arrhythmias.

Authors:  Ryan T Gardner; Crystal M Ripplinger; Rachel C Myles; Beth A Habecker
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-02

2.  Modeling the oxygen transport to the myocardium at maximal exercise at high altitude.

Authors:  Jean-Paul Richalet; Eric Hermand
Journal:  Physiol Rep       Date:  2022-04

3.  Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction.

Authors:  Yasuhide Mochizuki; Hidekazu Tanaka; Kensuke Matsumoto; Hiroyuki Sano; Hiromi Toki; Hiroyuki Shimoura; Junichi Ooka; Takuma Sawa; Yoshiki Motoji; Keiko Ryo; Yushi Hirota; Wataru Ogawa; Ken-ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2015-05-07       Impact factor: 9.951

4.  Effects of Na+ channel blockers on the restitution of refractory period, conduction time, and excitation wavelength in perfused guinea-pig heart.

Authors:  Oleg E Osadchii
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

5.  Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.

Authors:  Oleg E Osadchii
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 6.  Antiarrhythmic mechanisms of beta blocker therapy.

Authors:  Eleonora Grandi; Crystal M Ripplinger
Journal:  Pharmacol Res       Date:  2019-05-14       Impact factor: 7.658

7.  The role of G protein coupled receptor kinases in neurocardiovascular pathophysiology.

Authors:  Tijana Bojic; Emina Sudar; Dimitri Mikhailidis; Dragan Alavantic; Esma Isenovic
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

8.  Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathway.

Authors:  Ana P Davel; Patricia C Brum; Luciana V Rossoni
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

9.  Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman.

Authors:  Andrii Boguslavskyi; Davor Pavlovic; Karen Aughton; James E Clark; Jacqueline Howie; William Fuller; Michael J Shattock
Journal:  Cardiovasc Res       Date:  2014-08-07       Impact factor: 10.787

10.  Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death.

Authors:  Tyler Shugg; Andy Hudmon; Brian R Overholser
Journal:  J Am Heart Assoc       Date:  2020-08-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.